The relative rates of displacement of the NR2 group in (dialkylamido)titanatranes R2NTi(OCH2CH2)3N by -OH and -SH compounds is in the order NEt2 » NMe2 > N(/-Pr)2. This unanticipated order is rationalized on the i i postulated prior formation of HR2N+Ti(OCH2CH2)3N (A), which facilitates departure of R2NH upon subsequent nucleophilic attack. For R = Et and /-Pr, the concentration of A is higher than for R = Me, owing to the basicity order Et2N s (i-Pr)2N > Me2N. The greater reactivity of A where R = Me relative to R = /-Pr is attributed to the greater steric protection from nucleophilic attack on the metal afforded by the H(/-Pr)2N+ group. The faster reactions of CF3CH2OH and PhOH compared with their sterically similar but more weakly acidic analogues CH3CH2OH and /-PrOH, respectively, support this hypothesis as do the comparable displacement rates of Et2N and Me2N in the presence of the strong nonnucleophilic base P(MeNCH2CH2)3N and the reactions of 4 and 14 with HBF4 and NH4C1 but not with NaBF4 or Me4NCl. New titanatranyl derivatives reported include five arylates, i-1 two thioarylates, and four diolates. The X-ray parameters for [/-PrSTi(OCH2CH2)3N]2 are as follows: triclinic, space group Pi (No. 2), a = 7.434(5) A, b = 12.540
The reaction of TaCl 5 with 2 equiv of Li 2 [C 2 B 9 H 11 ] in refluxing toluene yields {(µ-H)-(C 2 B 9 H 10 ) 2 }TaCl 2 (1), which contains the unusual linked bis(carboranyl) ligand [(µ-H)-(C 2 B 9 H 10 ) 2 ] 3-, which is formed by formal oxidative coupling of two C 2 B 9 H 11 2ligands. Alkylation of 1 with ZnMe 2 yields {(µ-H)(C 2 B 9 H 10 ) 2 }TaMeCl (2), which retains the linked bis(carboranyl) ligand.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.